Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCSA Processa Pharmaceuticals, Inc.

交易中 10-08 14:02:09 EDT

1.36

-0.06

-4.23%

最高1.43	最低1.36	成交量1.09万
今开1.42	昨收1.42	日振幅5.01%
总市值379.90万	流通市值365.15万	总股本279.34万
成交额1.51万	换手率0.40%	流通股本268.49万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCSA","market":"US","secType":"STK","nameCN":"Processa Pharmaceuticals, Inc.","latestPrice":1.36,"timestamp":1791481506285,"preClose":1.42,"halted":0,"volume":10865,"delay":0,"changeRate":-0.042253521126760445,"floatShares":2684900,"shares":2793386,"eps":-5.59487,"marketStatus":"交易中","change":-0.06,"latestTime":"10-08 14:02:09 EDT","open":1.42,"high":1.43,"low":1.3589,"amount":15147.607071,"amplitude":0.05007,"askPrice":1.5,"askSize":104,"bidPrice":1.31,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.59487,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.42,"postHourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.42,"latestTime":"19:30 EDT","volume":208,"amount":295.385,"timestamp":1791415801709,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.940499},"requestUrl":"/m/hq/s/PCSA","defaultTab":"news","newsList":[{"id":"1175043662","title":"Processa Pharmaceuticals 宣布收购Vidya Therapeutics，同步进行约2亿美元私募融资，全力推进Btk抑制剂Vt-7208多疾病领域布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1175043662","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175043662?lang=zh_cn&edition=full","pubTime":"2026-07-29 19:31","pubTimestamp":1785324670,"startTime":"0","endTime":"0","summary":"Processa Pharmaceuticals, Inc. 正式对外公布，将收购Vidya Therapeutics, Inc.。与此同时，该公司还计划同步发起一项规模约为2亿美元的私募融资。这一系列资本运作的核心目标，在于加速推进其Btk抑制剂——Vt-7208——在多个疾病治疗领域的研发进程。此举标志着公司在肿瘤及自身免疫性疾病等关键战场上的战略纵深，进一步得到强化。通过整合Vidya的创新资产与管线，Processa有望在Btk靶点领域构筑更为坚实的技术壁垒与竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617576251","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617576251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2617576251?lang=zh_cn&edition=full","pubTime":"2026-03-05 23:36","pubTimestamp":1772725000,"startTime":"0","endTime":"0","summary":"北京时间2026年03月05日23时36分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.00%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.65%。其相关个股中，Impact Biomedical, Inc.、Ensysce Biosciences, Inc.、Tenaya Therapeutics, Inc.涨幅较大，Quince Therapeutics, Inc.、Impact Biomedical, Inc.、Ensysce Biosciences, Inc.较为活跃，换手率分别为334.82%、145.86%、57.45%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Impact Biomedical, Inc.、Tenaya Therapeutics, Inc.，振幅分别为49.85%、37.84%、33.32%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030523364095433116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030523364095433116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614918898","title":"Processa Pharmaceuticals, Inc.盘中异动 急速跳水5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614918898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614918898?lang=zh_cn&edition=full","pubTime":"2026-02-28 01:00","pubTimestamp":1772211639,"startTime":"0","endTime":"0","summary":"北京时间2026年02月28日01时00分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.83%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。其相关个股中，Ensysce Biosciences, Inc.、Edesa Biotech, Inc.、Neurogene Inc.涨幅较大，Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为6472.12%、566.48%、340.14%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Edesa Biotech, Inc.、Ensysce Biosciences, Inc.，振幅分别为82.34%、69.03%、51.85%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022801003997a75ab6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022801003997a75ab6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518274630","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.74%报0.515美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518274630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518274630?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613578,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅上涨6.74%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2042.36%、403.78%、59.56%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为99.91%、99.13%、98.72%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213258a26a251e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213258a26a251e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517192858","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517192858?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:39","pubTimestamp":1741289990,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时39分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速跳水7.66%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033951abebc101&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033951abebc101&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516038626","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516038626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516038626?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:26","pubTimestamp":1741101968,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时26分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.80%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232608abe7ffc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232608abe7ffc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634054","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅下挫5.26%报0.520美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516634054?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:44","pubTimestamp":1741013066,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时44分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Aldeyra Therapeutics, Inc.、Geovax Labs, Inc.涨幅较大，Entero Therapeutics Inc.、Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为99.60%、52.65%、43.38%，振幅较大的相关个股有Entero Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为55.45%、24.83%、22.27%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224426989a1333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224426989a1333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514633316","title":"Processa Pharmaceuticals, Inc.盘中异动 急速跳水5.67%报0.516美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514633316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514633316?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:23","pubTimestamp":1740677027,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时23分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.67%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Pepgen Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Ibio, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1719.86%、295.31%、124.40%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd，振幅分别为86.14%、50.65%、47.79%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801234798953193&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022801234798953193&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514166350","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514166350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514166350?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:39","pubTimestamp":1740497961,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时39分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.23%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1085.21%、1053.80%、602.38%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为224.93%、64.05%、61.16%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523392198925bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523392198925bb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513778982","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.55%报0.559美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513778982?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:10","pubTimestamp":1740409852,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时10分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.55%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为173.39%、74.39%、26.10%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231052abdb176f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224231052abdb176f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513329667","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅上涨7.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513329667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513329667?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:35","pubTimestamp":1740148554,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时35分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速上涨7.25%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为72.73%、65.34%、16.78%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.，振幅分别为33.83%、30.00%、25.39%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223554962b7c50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223554962b7c50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512335435","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.72%报0.565美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512335435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512335435?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:57","pubTimestamp":1739991478,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时57分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.72%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为670.86%、254.32%、228.87%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为267.43%、159.49%、65.50%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200257599628f7ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200257599628f7ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512816608","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅上涨5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512816608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512816608?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:44","pubTimestamp":1739889842,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时44分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.82%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224402abd3b212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218224402abd3b212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380597","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380597?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:38","pubTimestamp":1739284704,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时38分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.03%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2198.59%、560.12%、212.79%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为31.80%、26.96%、25.49%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223824a241fcce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223824a241fcce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510892585","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌8.30%报0.603美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510892585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510892585?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:07","pubTimestamp":1739218041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时07分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅下跌8.30%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Dominari Holdings Inc.、知临集团、Nls Pharmaceutics Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3176.57%、1685.60%、1446.79%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Biodexa Pharmaceuticals Plc、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为99.86%、95.28%、87.80%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110407219880b839&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110407219880b839&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509231720","title":"Processa Pharmaceuticals, Inc.盘中异动 快速上涨5.04%报0.625美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509231720?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:05","pubTimestamp":1738955147,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时05分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.04%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208030547abc662e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208030547abc662e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509251489","title":"Processa Pharmaceuticals, Inc.盘中异动 快速跳水5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509251489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509251489?lang=zh_cn&edition=full","pubTime":"2025-02-06 05:00","pubTimestamp":1738789238,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日05时00分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.79%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.97%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Invivyd, Inc.、Transcode Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4746.48%、2458.28%、1792.11%，振幅较大的相关个股有Oragenics Inc.、Invivyd, Inc.、Transcode Therapeutics, Inc.，振幅分别为132.24%、108.79%、99.51%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206050038abc3ccef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206050038abc3ccef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508014922","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅跳水6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508014922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508014922?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:34","pubTimestamp":1738593289,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时34分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速下跌6.14%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为349.46%、298.80%、137.26%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、26.50%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322344998796f8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322344998796f8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507663219","title":"Processa Pharmaceuticals, Inc.盘中异动 急速跳水6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507663219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507663219?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:36","pubTimestamp":1738334205,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时36分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速跳水6.14%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1413.08%、255.53%、64.36%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nutriband Inc C/Wts 、Nls Pharmaceutics Ltd.，振幅分别为62.40%、42.27%、30.81%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223645a2354341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223645a2354341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507219556","title":"Processa Pharmaceuticals, Inc.股价上涨17.02% 市值涨55.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507219556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507219556?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:31","pubTimestamp":1738247475,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时31分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速拉升17.02%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为583.70%、118.42%、93.09%，振幅较大的相关个股有Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Alterity Therapeutics Limited，振幅分别为17.92%、15.36%、10.65%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223115abbd4bfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223115abbd4bfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.processapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.1341},{"period":"1month","weight":-0.3107},{"period":"3month","weight":-0.2792},{"period":"6month","weight":-0.4874},{"period":"1year","weight":-0.8422},{"period":"ytd","weight":-0.5069}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司，正在开发下一代癌症治疗小分子管线，其中两个正在进行或已完成2期试验，一个正在进行临床前开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.125,"avgChangeRate":-0.211831},{"month":2,"riseRate":0.5,"avgChangeRate":0.029498},{"month":3,"riseRate":0.25,"avgChangeRate":-0.090874},{"month":4,"riseRate":0.25,"avgChangeRate":-0.083961},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.065267},{"month":6,"riseRate":0.555556,"avgChangeRate":0.07159},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.068826},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.097332},{"month":9,"riseRate":0.555556,"avgChangeRate":0.058028},{"month":10,"riseRate":0.222222,"avgChangeRate":0.0073},{"month":11,"riseRate":0.375,"avgChangeRate":0.039964},{"month":12,"riseRate":0.25,"avgChangeRate":-0.217572}],"exchange":"NASDAQ","name":"Processa Pharmaceuticals, Inc.","nameEN":"Processa Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Processa Pharmaceuticals, Inc.,PCSA,Processa Pharmaceuticals, Inc.股票,Processa Pharmaceuticals, Inc.股票老虎,Processa Pharmaceuticals, Inc.股票老虎国际,Processa Pharmaceuticals, Inc.行情,Processa Pharmaceuticals, Inc.股票行情,Processa Pharmaceuticals, Inc.股价,Processa Pharmaceuticals, Inc.股市,Processa Pharmaceuticals, Inc.股票价格,Processa Pharmaceuticals, Inc.股票交易,Processa Pharmaceuticals, Inc.股票购买,Processa Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}